Next Milestone Ventures

Mirimus is changing the paradigm of the current drug discovery process by developing superior preclinical RNA interference (RNAi) animal models that can predict toxicities of potential drug therapies without the actual drug itself.

Team:
Prem Premsrirut – Founder, CEO, President
Chia-Lin Wang – Director of Genetic Engineering Services
Yu-Ting Yang -Director of Embryology